LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 14.000 pounds of LORATADINE TABLETS with NSN 6505013770448 at a total price of $280.14. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms where the contractor assumes all transportation costs and risks until receipt at the designated location. The item is procured as a single line item with zero variance allowed in quantity, and acceptance is contingent upon government inspection at the point of delivery. The contractor is certified as a small business and a women-owned small business, triggering compliance with FAR Part 19 and 13 CFR Part 127, including ongoing reporting and SAM.gov verification obligations. Packaging must be shipped via the fastest traceable means without parcel post, and all shipments must be marked with the order identifier W8002S61030294 and the contract blocks 1 and 2 information. No specific MIL-STD, preservation, or bar-coding standards are cited, though compliance with federal pharmaceutical codes and the parent contract’s terms is required. Payments will be processed through DEF FIN AND ACCOUNTING SVC, BSM, using remittance address P O BOX 182317, COLUMBUS OH 43218-2317, with payment code SL4701. The contracting officer is Lisa Quinn, and the local administrative contact is Shairy M. Cartagena, with no formal COR or COTR designated. The acquisition falls under NAICS code 424210 and is administered through a basic IDIQ contract framework, though the specific contract type is not explicitly declared. No clause numbers or special requirements such as security clearances, key personnel, or OCI provisions are included in the documentation.